Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT — Stella

Home/Patent Ductus Arteriosus/

View on ClinicalTrials.gov

Recruiting

Back to Patent Ductus Arteriosus trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Canada

McMaster Children's Hospital - Neonatal Intensive Care Unit, Hamilton, Ontario

Key details

Phase

Safety & dosing

Sponsor

Hamilton Health Sciences Corporation

Collaborators

McMaster University, Hamilton Academic Health Sciences Organization

Enrollment target

~26 participants

Started

July 2024

Primary completion

July 2026

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.